📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis. (2024)

First Author: Wannan CMJ

Attributed to: Psychosis Immune Mechanism Stratified Medicine Study (PIMS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/schbul/sbae011

PubMed Identifier: 38451304

Publication URI: http://europepmc.org/abstract/MED/38451304

Type: Journal Article/Review

Volume: 50

Parent Publication: Schizophrenia bulletin

Issue: 3

ISSN: 0586-7614